학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 111건 | 목록 1~20
Academic Journal
Torres VO; Denali Therapeutics, South San Francisco, CA, USA.; Pizzo ME; Denali Therapeutics, South San Francisco, CA, USA.; Chan D; Denali Therapeutics, South San Francisco, CA, USA.; Dugas JC; Denali Therapeutics, South San Francisco, CA, USA.; Huynh D; Denali Therapeutics, South San Francisco, CA, USA.; Joy D; Denali Therapeutics, South San Francisco, CA, USA.; Liang EK; Denali Therapeutics, South San Francisco, CA, USA.; Sarrafha L; Denali Therapeutics, South San Francisco, CA, USA.; Becerra I; Denali Therapeutics, South San Francisco, CA, USA.; Chau R; Denali Therapeutics, South San Francisco, CA, USA.; Chew KS; Denali Therapeutics, South San Francisco, CA, USA.; Chow J; Denali Therapeutics, South San Francisco, CA, USA.; Discenza CB; Denali Therapeutics, South San Francisco, CA, USA.; Earr TK; Denali Therapeutics, South San Francisco, CA, USA.; Furaso L; Denali Therapeutics, South San Francisco, CA, USA.; Khoury N; Denali Therapeutics, South San Francisco, CA, USA.; Lechtenberg KJ; Denali Therapeutics, South San Francisco, CA, USA.; Leung AW; Denali Therapeutics, South San Francisco, CA, USA.; Nguyen HN; Denali Therapeutics, South San Francisco, CA, USA.; Ojo ES; Denali Therapeutics, South San Francisco, CA, USA.; Roche E; Denali Therapeutics, South San Francisco, CA, USA.; Simon MJ; Denali Therapeutics, South San Francisco, CA, USA.; Solanoy H; Denali Therapeutics, South San Francisco, CA, USA.; Tong M; Denali Therapeutics, South San Francisco, CA, USA.; Tong RK; Denali Therapeutics, South San Francisco, CA, USA.; Henne K; Denali Therapeutics, South San Francisco, CA, USA.; Lewcock JW; Denali Therapeutics, South San Francisco, CA, USA.; Watts RJ; Denali Therapeutics, South San Francisco, CA, USA.; Calvert ME; Denali Therapeutics, South San Francisco, CA, USA.; Thorne RG; Denali Therapeutics, South San Francisco, CA, USA.; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA.; Zuchero YJY; Denali Therapeutics, South San Francisco, CA, USA.
Publisher: SAGE Publications Country of Publication: United States NLM ID: 8112566 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-7016 (Electronic) Linking ISSN: 0271678X NLM ISO Abbreviation: J Cereb Blood Flow Metab Subsets: MEDLINE
Academic Journal
Wells RC; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. Electronic address: wells@dnli.com.; Akkapeddi P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Chan D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Joy D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Moshkforoush A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Chau R; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Chow J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Cherf GM; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Chien EYT; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Clemens A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Pizzo ME; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Qerqez AN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Tran T; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Becerra I; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Dugas JC; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Duque J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Earr TK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Huynh D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Kim DJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Wing-Sze Leung A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Liang E; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Nguyen HN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Robles-Colmenares Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Kane H; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Roche E; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Sacayon P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Xa K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Solanoy H; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Dennis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Lewcock JW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Watts RJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Kariolis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Thorne RG; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA.; Koth CM; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Calvert MEK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.; Yu Zuchero YJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. Electronic address: zuchero@dnli.com.; Chew KS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. Electronic address: chew@dnli.com.
Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Chew KS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Wells RC; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Moshkforoush A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Chan D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Lechtenberg KJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Tran HL; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Chow J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Kim DJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Robles-Colmenares Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Srivastava DB; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Tong RK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Tong M; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Xa K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Yang A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Zhou Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Akkapeddi P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Annamalai L; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Bajc K; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Blanchette M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Cherf GM; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Earr TK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Gill A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Huynh D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Joy D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Knight KN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Lac D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Leung AW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Lexa KW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Liau NPD; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Becerra I; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Malfavon M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; McInnes J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Nguyen HN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Lozano EI; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Pizzo ME; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Roche E; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Sacayon P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Calvert MEK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Daneman R; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Dennis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Duque J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Gadkar K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Lewcock JW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Mahon CS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Meisner R; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Solanoy H; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Thorne RG; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA.; Watts RJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Zuchero YJY; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. zuchero@dnli.com.; Kariolis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. kariolis@dnli.com.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Chew KS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Wells RC; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Moshkforoush A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Chan D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Lechtenberg KJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Tran HL; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Chow J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Kim DJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Robles-Colmenares Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Srivastava DB; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Tong RK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Tong M; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Xa K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Yang A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Zhou Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Akkapeddi P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Annamalai L; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Bajc K; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Blanchette M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Cherf GM; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Earr TK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Gill A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Huynh D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Joy D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Knight KN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Lac D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Leung AW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Lexa KW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Liau NPD; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Becerra I; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Malfavon M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; McInnes J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Nguyen HN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Lozano EI; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Pizzo ME; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Roche E; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Sacayon P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Calvert MEK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Daneman R; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Dennis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Duque J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Gadkar K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Lewcock JW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Mahon CS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Meisner R; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Solanoy H; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Thorne RG; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA.; Watts RJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Zuchero YJY; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. zuchero@dnli.com.; Kariolis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. kariolis@dnli.com.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Jennings D; Denali Therapeutics Inc., South San Francisco, CA, USA.; Huntwork-Rodriguez S; Denali Therapeutics Inc., South San Francisco, CA, USA.; Henry AG; Denali Therapeutics Inc., South San Francisco, CA, USA.; Sasaki JC; Denali Therapeutics Inc., South San Francisco, CA, USA.; Meisner R; Denali Therapeutics Inc., South San Francisco, CA, USA.; Diaz D; Denali Therapeutics Inc., South San Francisco, CA, USA.; Solanoy H; Denali Therapeutics Inc., South San Francisco, CA, USA.; Wang X; Denali Therapeutics Inc., South San Francisco, CA, USA.; Negrou E; Denali Therapeutics Inc., South San Francisco, CA, USA.; Bondar VV; REGENXBIO, Rockville, MD, USA.; Ghosh R; Denali Therapeutics Inc., South San Francisco, CA, USA.; Maloney MT; Denali Therapeutics Inc., South San Francisco, CA, USA.; Propson NE; Denali Therapeutics Inc., South San Francisco, CA, USA.; Zhu Y; Denali Therapeutics Inc., South San Francisco, CA, USA.; Maciuca RD; Denali Therapeutics Inc., South San Francisco, CA, USA.; Harris L; Denali Therapeutics Inc., South San Francisco, CA, USA.; Kay A; Denali Therapeutics Inc., South San Francisco, CA, USA.; LeWitt P; Henry Ford Health System, Detroit, MI, USA.; King TA; Covance, Dallas, TX, USA.; Kern D; University of Colorado, School of Medicine, Aurora, CO, USA.; Ellenbogen A; Michigan Institute for Neurological Disorders, Farmington Hills, MI, USA.; Goodman I; Bioclinica Research, Orlando, FL, USA.; Siderowf A; University of Pennsylvania, Penn Neurology Pennsylvania Hospital, Philadelphia, PA, USA.; Aldred J; Inland Northwest Research, Spokane, WA, USA.; Omidvar O; Collaborative Neuroscience Research, Long Beach, CA, USA.; Masoud ST; Denali Therapeutics Inc., South San Francisco, CA, USA.; Davis SS; Denali Therapeutics Inc., South San Francisco, CA, USA.; Arguello A; Denali Therapeutics Inc., South San Francisco, CA, USA.; Estrada AA; Denali Therapeutics Inc., South San Francisco, CA, USA.; de Vicente J; Denali Therapeutics Inc., South San Francisco, CA, USA.; Sweeney ZK; Interline Therapeutics, South San Francisco, CA, USA.; Astarita G; Denali Therapeutics Inc., South San Francisco, CA, USA.; Henry Ford Health System, Detroit, MI, USA.; Borin MT; Denali Therapeutics Inc., South San Francisco, CA, USA.; Wong BK; Denali Therapeutics Inc., South San Francisco, CA, USA.; Wong H; University of British Columbia, Vancouver, BC, Canada.; Nguyen H; Denali Therapeutics Inc., South San Francisco, CA, USA.; Scearce-Levie K; Denali Therapeutics Inc., South San Francisco, CA, USA.; Ho C; Denali Therapeutics Inc., South San Francisco, CA, USA.; Troyer MD; Denali Therapeutics Inc., South San Francisco, CA, USA.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Solanoy, H.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어